Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies

Blood

Volumn 95, Issue 11, 2000, Pages 3423-3428

  Pinotti, Mirko ^b   Toso, Raffaella ^b   Girelli, Domenico ^b   Bindini, Debora ^b   Ferraresi, Paolo ^b   Papa, Maria L ^b   Corrocher, Roberto ^b   Marchetti, Giovanna ^b   Bernardi, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; RNA;

ALLELE; ANIMAL CELL; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CELL STRAIN BHK; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SPLICING;

EID: 0034210180     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3423.011k04_3423_3428     Document Type: Article

References (53)

1. Hedner U, Davie EW. Introduction to hemostasis and the vitamin K-dependent coagulation factors. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, McGraw-Hill; 1989:2107-2134.
2. Rapaport SI, Rao RVM. The tissue factor pathway: how it has become a "prima ballerina.qout; Thromb Haemost. 1995;74:7-17.
3. Edgington TS, Dickinson CD, Ruf W. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation. Thromb Haemost. 1997;78:401-405.
4. Cooper DN, Millar DS, Wacey A, Banner DW, Tuddenham EGD. Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost. 1997;78:151-160.
5. Rosen ED, Chan JC, Idusogie E, et al. Mice lacking factor VII develop normally but suffer latal perinatal bleeding. Nature. 1997;390:290-294.
6. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
7. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
8. Moor E, Silveira A, van't Hooft F, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age: role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol. 1995;15:655-664.
9. Philippou H, Adami A, Amersey RA, Stubbs PJ, Lane DA. A novel specific immunoassay for plasma two-chain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes. Blood. 1997;89: 767-775.
10. Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. QJM. 1994;87:403-406.
11. Wang XL, Wang J, McCredie RM, Wilcken DE. Polymorphisms of factor V, factor VII, and fibrinogen genes: relevance to severity of coronary artery disease. Arterioscler Thromb Vasc Biol. 1997;17:246-251.
12. Doggen CJ, Manger Cats V, Bertina RM, Reitsma PH, Vandenbroucke JP, Rosendaal FR. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost. 1998;80:281-285.
13. Heywood DM, Carter AM, Catto AJ, Bamford JM, Grant PJ. Polymorphisms of the factor VII gene and circulating FVII: C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke. 1997;28:816-821.
14. Scarabin PY, Aillaud MF, Amouyel P, et al. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction -the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost. 1998;80:749-756.
15. Lane A, Green F, Scarabin PY, et al. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis. 1996;119:119-127.
16. Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol. 1999;19:1776-1783.
17. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997;96:1102-1108.
18. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1999;100:736-742.
19. Junker R, Heinrich J, Schulte H, van de Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol. 1997;17:1539-1544.
20. Mennen LI, Schouten EG, Grobbee DE, Kluft C. Coagulation factor VII, dietary fat and blood lipids: a review. Thromb Haemost. 1996;76:492-499.
21. Miller GJ, Martin JC, Mitropoulos KA, et al. Activation of FVII during alimentary lipidemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency. Blood. 1996;87:4187-4196.
22. Green F, Kelleher C, Wilkes H, Temple A, Meade TW, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb. 1991;11:540-546.
23. Lane A, Cruickshank JK, Stewart J, Henderson A, Humpries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in different ethnic groups at differing risk of coronary heart disease. Artheriosclerosis. 1992;94:43-50.
24. Bernardi F, Marchetti G, Pinotti M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol. 1996;16:72-76.
25. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb. 1994;14:193-198.
26. Green F, Humphries S. Genetic determinants of arterial thrombosis. Baillière's Clin Haematol. 1994;7:675-692.
27. Heywood DM, Ossei-Gerning N, Grant PJ. Association of factor VII: C levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterised by angiography. Thromb Haemost. 1996;76: 161-165.
28. Bernardi F, Arcieri P, Bertina RM, et al. Contribution of Factor VII genotype to activated FVII levels: differences in genotype frequencies between northern and southern European population. Arterioscler Thromb Vasc Biol. 1997;17:2548-2553.
29. Pollak ES, Hung HL, Godin W, Overton GC, High KA. Functional characterization of the human factor VII 5′ flanking region. J Biol Chem. 1996;271: 1738-1747.
30. van't Hooft FM, Silveira A, Tornvall P, et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood. 1999;93:3432-3441.
31. O'Hara PJ, Grant FJ, Haldeman BA, et al. Nucleotide sequence of the gene coding for the human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A. 1987;84:5158-5162.
32. Greenberg D, Miao CH, Ho WT, Chung DW, Davie EW. Liver-specific expression of the human factor VII gene. Proc Natl Acad Sci U S A. 1995; 92:12,347-12,351.
33. Carew JA, Pollak ES, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter. Blood. 1998;92:1639-1645.
34. Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of coagulation factor VII: in vivo and in vitro studies. Arterioscler Thromb Vasc Biol. 1997; 17:2825-2829.
35. O'Hara PJ, Grant FJ. The human factor VII gene is polymorphic due to variation in repeat copy number in a minisatellite. Gene. 1988;66:147-158.
36. Marchetti G, Gemmati D, Patracchini P, Pinotti M, Bernardi F. PCR detection of a repeat polymorphism within the F7 gene. Nucleic Acids Res. 1991;19:4570.
37. Marchetti G, Patracchini P, Gemmati D, et al. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7). Hum Genet. 1992;89:497-502.
38. Pinotti M, Toso R, Redalli R, Berrettini M, Marchetti G, Bernardi F. Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene. Blood. 1998;92:1646-1651.
39. Iacoviello L, Di Castelnuovo A, de Knijff P, et al. Polymorphism in the coagulation factor VII gene and risk of myocardial infarction. N Eng J Med. 1998;338:79-85.
40. Krontiris TG. Minisatellites and human disease. Science. 1995;269:1682-1683.
41. Bernardi F, Castaman G, Pinotti M, et al. Mutation pattern in clinically asymptomatic coagulation factor VII deficiency. Hum Mut. 1996;8:108-115.
42. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet. 1993;90: 575-576.
43. Bernardi F, Patracchini P, Gemmati D, et al. Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. Hum Genet. 1993;92:446-450.
44. Wang XL, Mahaney MC, Sim AS, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997;17:3147-3153.
45. Dawson SJ, Wiman B, Hamster A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in hepG2 cells. J Biol Chem. 1993;268:10,739-10,745.
46. Dominski Z, Kole R. Cooperation of pre-mRNA sequence elements in splice site selection. Mol Cell Biol. 1992;12:2108-2114.
47. Sterner DA, Berget SM. In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit. Mol Cell Biol. 1993;13:2677-2687.
48. Dominski Z, Kole R. Identification of exon sequences involved in splice site selection. J Biol Chem. 1994;269:23,590-23,596.
49. Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood donor population. Thromb Haemost. 1994;72:21-27.
50. Sirand-Pugnet P, Durosay P, Brody E, Marie J. An intronic (A/U) GGG repeat enhances the splicing of an alternative intron of the chicken β-tropomyosin pre-mRNA. Nucleic Acids Res. 1995;23: 3501-3507.
51. McCullough AJ, Berget SM. G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol Cell Biol. 1997;7:4562-4571.
52. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987;15:7155-7174.
53. Saad S, Rowley G, Tagliavacca L, Green PM, Giannelli G, UK Haemophilia Centres. First report on UK database of Haemophilia B mutations and pedigrees. Thromb Haemost. 1994;71:563-570.